WallStreetZenWallStreetZen

NASDAQ: BRNS
Barinthus Biotherapeutics PLC Stock Ownership - Who owns Barinthus Biotherapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Barinthus Biotherapeutics PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph ScheerenDirector2023-06-2610,000$2.44
$24.40kBuy
Robin WrightDirector2023-05-2513,750$2.66
$36.62kBuy

1 of 1

BRNS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRNS insiders and whales buy or sell their stock.

BRNS Shareholders

What type of owners hold Barinthus Biotherapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Oxford Sciences Innovation PLC22.60%8,797,770$23.05MInsider
Mg Investment Management Ltd15.83%6,160,946$16.14MInsider
Mg Investment Management Ltd13.35%5,197,349$13.62MInstitution
Mg Alternatives Investment Management Ltd10.56%4,108,752$10.76MInsider
William Enright4.56%1,773,300$4.65MInsider
Alphabet Inc3.89%1,513,644$3.97MInstitution
Hsg Holding Ltd3.65%1,420,473$3.72MInstitution
Dc Funds LP1.65%642,204$1.68MInstitution
Bluecrest Capital Management Ltd1.39%542,673$1.42MInstitution
Baird Financial Group Inc0.50%196,296$514.30kInstitution

1 of 3

BRNS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRNS24.97%54.37%Net Buying
VANI2.51%97.49%Net BuyingNet Buying
CLRB26.67%12.70%
ANIX13.83%84.70%Net BuyingNet Buying
VIGL44.03%55.97%Net Buying
View Top Biotech Stocks

Barinthus Biotherapeutics Stock Ownership FAQ

Who owns Barinthus Biotherapeutics?

Barinthus Biotherapeutics (NASDAQ: BRNS) is owned by 24.97% institutional shareholders, 54.37% Barinthus Biotherapeutics insiders, and 20.66% retail investors. Oxford Sciences Innovation PLC is the largest individual Barinthus Biotherapeutics shareholder, owning 8.80M shares representing 22.60% of the company. Oxford Sciences Innovation PLC's Barinthus Biotherapeutics shares are currently valued at $22.43M.

If you're new to stock investing, here's how to buy Barinthus Biotherapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.